Decision Diagnostics Pre-Tax Profit Margin 2010-2011 | DECN

Decision Diagnostics pre-tax profit margin from 2010 to 2011. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Decision Diagnostics Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2011-09-30 $0.02B $0.00B -6.25%
2011-06-30 $0.02B $0.00B -5.88%
2011-03-31 $0.02B $0.00B -5.56%
2010-12-31 $0.02B $0.00B -5.26%
2010-09-30 $0.02B 0 0.00%
2010-06-30 $0.02B 0 0.00%
2010-03-31 $0.02B $0.00B 5.56%
2009-12-31 $0.02B $0.00B 5.26%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.000B $0.000B
Decision Diagnostics Corp. is engaged in developing products that offer solutions in medical care and management by providing physicians with information at the point of care. The Company uses smart phones which allow physicians to carry, access and update their patients' histories, medication data, and best care guidelines at the point of care. Decision Diagnostics Corp. is a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies. Decision Diagnostics Corp., formerly known as Instacare Corp., is based in Westlake Village, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.557B 53.26
Tempus AI (TEM) United States $9.312B 0.00
Hims & Hers Health (HIMS) United States $9.304B 97.39
Inspire Medical Systems (INSP) United States $4.724B 73.15
IRhythm Technologies (IRTC) United States $4.334B 0.00
Privia Health (PRVA) United States $2.788B 208.91
Enovis (ENOV) United States $1.951B 12.07
Schrodinger (SDGR) United States $1.898B 0.00
Clover Health Investments (CLOV) United States $1.712B 0.00
Phreesia (PHR) United States $1.483B 0.00
Omnicell (OMCL) United States $1.428B 30.80
Azenta (AZTA) United States $1.197B 55.74
10x Genomics (TXG) United States $1.053B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Butterfly Network (BFLY) United States $0.539B 0.00
Talkspace (TALK) United States $0.527B 313.00
Veradigm (MDRX) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.437B 0.00
TruBridge (TBRG) United States $0.393B 0.00
Claritev (CTEV) United States $0.346B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.221B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
Pulmonx (LUNG) United States $0.144B 0.00
American Well (AMWL) United States $0.114B 0.00
Retrieve Medical Holdings (RMHI) United States $0.095B 0.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
MDxHealth SA (MDXH) Belgium $0.083B 0.00
CareCloud (CCLD) United States $0.074B 3.18
111 (YI) China $0.070B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00